About Injective
Injective is a company based in New York (United States) founded in 2018 by Albert Chon and Eric Chen. It operates as a Blockchain-as-a-Service, and Token / Crypto Economy. Injective has raised $95.2 million across 5 funding rounds from investors including BlockTower, QCP Capital and Jump Crypto. Injective offers products and services including Injective Blockchain, Injective Wallet, and INJ Token. Injective operates in a competitive market with competitors including Consensys, Luno, Ripple, Amber Group and Matrixport, among others.
- Headquarter New York, United States
- Founders Albert Chon, Eric Chen
-
Sectors
TechnologyFinancial Services
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Injective Foundation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$95.2 M (USD)
in 5 rounds
-
Latest Funding Round
$40 M (USD), Series B
Aug 15, 2022
-
Investors
BlockTower
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Injective
Injective offers a comprehensive portfolio of products and services, including Injective Blockchain, Injective Wallet, and INJ Token. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A blockchain platform is provided for financial applications.
A wallet service is offered for asset management.
Native utility token is used within the ecosystem.
Unlock access to complete
Funding Insights of Injective
Injective has successfully raised a total of $95.2M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $40.0M
-
First Round
First Round
(28 Jul 2020)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series B - Injective | Valuation |
investors |
|
| Aug, 2022 | Amount | Series A - Injective | Valuation | Jump Crypto | |
| Apr, 2021 | Amount | Seed - Injective | Valuation | Pantera Capital , BlockTower |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Injective
Injective has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include BlockTower, QCP Capital and Jump Crypto. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Blockchain-focused investment funds and venture capital are provided.
|
Founded Year | Domain | Location | |
|
Cryptocurrency and digital asset investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on crypto-assets
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Injective
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Injective
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Injective Comparisons
Competitors of Injective
Injective operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Consensys, Luno, Ripple, Amber Group and Matrixport, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of blockchain and web3 software platform
|
|
| domain | founded_year | HQ Location |
Mobile app for storing and trading cryptocurrencies is utilized.
|
|
| domain | founded_year | HQ Location |
Blockchain-based payment network for cross-border transfers is developed.
|
|
| domain | founded_year | HQ Location |
Blockchain-based financial solutions are offered for crypto trading and payments.
|
|
| domain | founded_year | HQ Location |
App-based platform offering crypto investment products and financial services solutions
|
|
| domain | founded_year | HQ Location |
An app-based platform is offered for cryptocurrency trading and investments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Injective
Frequently Asked Questions about Injective
When was Injective founded?
Injective was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Injective located?
Injective is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Injective a funded company?
Injective is a funded company, having raised a total of $95.2M across 5 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Jul 28, 2020.
What does Injective do?
A specialized blockchain is built by Injective for finance and Web3 innovation. Financial applications are supported through plug-and-play modules that simplify development. Technical complexities are abstracted to enable hyper-performant applications with minimal barriers. The ecosystem is recognized as one of the largest and fastest-growing in Web3 finance, connecting various dApps, chains, and institutions. Solutions like asset bridging and staking are provided to enhance user engagement in decentralized finance.
Who are the top competitors of Injective?
What products or services does Injective offer?
Injective offers Injective Blockchain, Injective Wallet, and INJ Token.
Who are Injective's investors?
Injective has 17 investors. Key investors include BlockTower, QCP Capital, Jump Crypto, Brevan Howard, and Pantera Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.